U.S., Jan. 24 -- ClinicalTrials.gov registry received information related to the study (NCT07363161) titled 'Drug-coated Balloon (DCB) vs. Drug-eluting Stent (DES) in High-risk Patients With Coronary Artery Disease (CAD)' on Jan. 15.
Brief Summary: The main objective of this randomized, multicenter, international, open-label clinical trial is to demonstrate that, in the context of percutaneous coronary intervention for complex coronary artery disease, a SeQuent(R) SCB interventional strategy is non-inferior to a new-generation
DES strategy in terms of a 12- and 36-month composite of Target Vessel Failure (TVF), that includes:
* cardiovascular death (CV death),
* target vessel related MI (TV-MI),
* clinically indicated target vessel rev...